tm logo
KISIMA
Live/Registered
REGISTERED

on 09 Oct 2018

Last Applicant/ Owned by

c/o Fondation pour Recherches Médicales

Geneva 1205

CH

Serial Number

87149001 filed on 24th Aug 2016

Registration Number

5577986 registered on 09th Oct 2018

in the Principal Register

Correspondent Address

Jennifer Fraser

JENNIFER FRASER

1301 K STREET, NW

SUITE 1100 WEST

WASHINGTON, DC 20005

Filing Basis

No Filing Basis

Disclaimer

NO DATA

KISIMA

Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceuticals, medicine, biochemistry and biotechnology, and design of biochemical macromolecules, in particular proteins, peptides and nucleic acids, and biochemical preparations for scientific, medical and industrial use; Industrial analysis and rese Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services, namely, pest control for agriculture, horticulture and forestry, farming services in the field of grain; Pharmaceutical services, namely, pharmaceutical advice, pharmaceutical compounding services; Medical information

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceuticals, medicine, biochemistry and biotechnology, and design of biochemical macromolecules, in particular proteins, peptides and nucleic acids, and biochemical preparations for scientific, medical and industrial use; Industrial analysis and research services in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to science; medical product and pharmaceutical research and development services; biological scientific research and development and clinical scientific research and development services; research and development services all relating to industry in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical, biochemical, medical and pharmaceutical research; medical and pharmacological research services; medical research; scientific research for medical purposes; laboratory research services in the field of protein, peptide and molecular biology; provision of information and data relating to medical product and scientific research and development; medical and pharmaceutical product development and evaluation; Pharmaceutical, medical, biotechnological and biochemical research and development services for the pharmaceutical industry; Information technology services for the pharmaceutical and healthcare industries, namely, planning, design and management of information technology systems, consulting in the field of information technology, design and development of computer software

Class [005]
Pharmaceutical Products


Pharmaceutical, medical and veterinary preparations, namely, proteins, peptides, and modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules, namely, peptides, proteins, nucleic acids and derivatives of peptides, proteins, and nucleic acids for medical and pharmaceutical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; diagnostic preparations for medical and veterinary use; biological preparations, namely, proteins, peptides, modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; cells for medical purposes; pharmaceutical preparations and compositions, namely, pharmaceutical preparations and compositions for the treatment and prevention of cancer; nucleic acids, in particular recombinant nucleic acids; nucleic acids for medical purposes, namely, for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; nucleic acid sequences for medical purposes, namely, for diagnostic purposes and the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins for medical purposes, namely, for diagnostic purposes and for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules and biologically active substances for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; kits containing preparations for medical purposes, comprised primarily of pharmaceutical preparations for the treatment and prevention of tumor and cancer diseases, and pharmaceutical preparations namely, proteins, peptides, modified peptides for the treatment and prevention of infectious diseases, and autoimmune diseases

Class [001]
Chemical Products


The English translation of "KISIMA" in the mark is "WATER WELL".

Mark Details


Serial Number

No 87149001

Mark Type

No Service Mark

Attorney Docket Number

No 067249-0016

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Oct 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09th Oct 2018REGISTERED-PRINCIPAL REGISTER
24th Jul 2018PUBLISHED FOR OPPOSITION
24th Jul 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04th Jul 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20th Jun 2018APPROVED FOR PUB - PRINCIPAL REGISTER
18th Jun 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
18th Jun 2018TEAS/EMAIL CORRESPONDENCE ENTERED
11th Jun 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Jun 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED